
(AGENPARL) – SILVER SPRING mer 05 aprile 2023 On May 4, 2023, the U.S. Food and Drug Administration (FDA) is hosting a webinar for patients, industry, and other interested stakeholders to discuss and answer questions about the draft guidance: Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments into Endpoints
Fonte/Source: http://www.fda.gov/drugs/news-events-human-drugs/public-webinar-patient-focused-drug-development-incorporating-clinical-outcome-assessments-endpoints